Karina Vargová

5-Azacitidine in aggressive myelodysplastic syndromes regulates chromatin structure at PU.1 gene and cell differentiation capacity

Nikola Čuřík, Pavel Burda, Karina Vargová et al. · Leukemia · 2012 · 42 citations

Chromatin, Pu.1 Gene, Chromatin Structure +12

Aggressive acute myeloid leukemia in PU.1/p53 double-mutant mice

Petra Bašová, Vít Pospíšil, Filipp Savvulidi et al. · Oncogene · 2013 · 27 citations

Hematological Malignancy, Mixed-phenotype Acute Leukemia, Hematology +5

Oncogenic microRNA-155 and its target PU.1: an integrative gene expression study in six of the most prevalent lymphomas

Hana Hušková, Katarina Korecka, Josef Karban et al. · International Journal of Hematology · 2015 · 22 citations

Prevalent Lymphomas, Immunology, Pathology +8

Modeling cancer driver events in vitro using barrier bypass-clonal expansion assays and massively parallel sequencing

Hana Hušková, Maude Ardin, Annette Weninger et al. · Oncogene · 2017 · 13 citations · Full text

Somatic mutation dynamics in MDS patients treated with azacitidine indicate clonal selection in patients-responders

Kamila Polgárová, Karina Vargová, Vojtěch Kulvait et al. · Oncotarget · 2017 · 10 citations · Full text